Subscribe: NewswireToday - Free Press Release - Free Newswire Distribution - Pharma/BioTech/Nutrition
http://www.newswiretoday.com/xml/17/
Preview: NewswireToday - Free Press Release - Free Newswire Distribution - Pharma/BioTech/Nutrition

NewswireToday - Free Press Release - Free Newswire Distribution - Pharma/BioTech/Nutrition



Recent Pharma/BioTech/Nutrition NewswireToday - PRZOOM Headline News - Visit PressReleasesNewswireDistribution.com



Published: Sun, 23 Apr 2017 20:40:35 -0400

 



First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads

2017/04/20

NewswireToday (newswire) - 2017/04/20 London, United Kingdom - BTG plc, a global specialist healthcare company, announced the treatment of the first patients in the EU with DC Bead LUMI™ - DCBeadLUMI.com / BTG-IM.com



FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy

2017/04/17

NewswireToday (newswire) - 2017/04/17 South San Francisco, CA United States - FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy, the Leading Cause of Blindness Among Working Age Adults in the United States - Gene.com



Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan

2017/04/13

NewswireToday (newswire) - 2017/04/13 London, United Kingdom - Demand for analyzers expected from emerging economies that will become manufacturing hubs, finds Frost & Sullivan’s Measurement & Instrumentation team - Frost.com



BD Completes Acquisition of Caesarea Medical Electronics

2017/04/04

NewswireToday (newswire) - 2017/04/04 Franklin Lakes, NJ United States - Expands Infusion Portfolio for Ambulatory, Home Care and Specialty Applications - CME-Infusion.com / BD.com



MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

2017/04/04

NewswireToday (newswire) - 2017/04/04 Irvine, CA United States - MDxHealth SA announced that it has signed an exclusive licensing deal with Ghent University in Belgium for its proprietary molecular diagnostic visualization technology - UGent.be / MDxHealth.com



Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals

2017/04/03

NewswireToday (newswire) - 2017/04/03 Paris, Ile-de-France France - Ipsen announced that it has completed its acquisition of global oncology assets from Merrimack Pharmaceuticals, in Cambridge, MA - ONIVYDE.com / IPSENUS.com



FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris

2017/03/23

NewswireToday (newswire) - 2017/03/23 South San Francisco, CA United States - Genentech announced that FDA has granted Breakthrough Therapy Designation status to Rituxan® (rituximab) for pemphigus vulgaris, a rare, serious and life-threatening condition characterized by progressive painful blistering of the skin and mucous membrane



MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom

2017/03/21

NewswireToday (newswire) - 2017/03/21 Irvine, CA United States - MDxHealth SA announced that it has signed a distribution agreement to make its SelectMDx™ for Prostate Cancer test available to Lab21 Clinical Laboratory's urology clients in the United Kingdom - Lab21.com / MDxHealth.com



Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions

2017/03/17

NewswireToday (newswire) - 2017/03/17 King of Prussia, PA United States - Company Announces Premiere Sponsorship of European Site Solutions Summit; Executives to Lead Several Key Discussions Around Site Payments and Patient Reimbursements - Greenphire.com



Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer

2017/03/13

NewswireToday (newswire) - 2017/03/13 Paris, Ile-de-France France - Ipsen announced that the MHRA in the UK has approved a new indication for Decapeptyl® as adjuvant treatment - IPSEN.com



SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic

2017/03/08

NewswireToday (newswire) - 2017/03/08 Irvine, CA United States - MDxHealth SA announced that SelectMDx™ for Prostate Cancer, a non-invasive urine-based test that guides patient selection for prostate biopsy, will be used for the newly launched prostate cancer risk clinic at the University of Michigan - MDxHealth.com



BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead

2017/03/07

NewswireToday (newswire) - 2017/03/07 London, United Kingdom - BTG plc announced it has received Class III CE Mark certification for DC Bead LUMI™ - DCBeadLUMI.com / BTG-IM.com



Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience

2017/03/03

NewswireToday (newswire) - 2017/03/03 Goettingen, Germany - Sartorius will purchase Essen BioScience for $320 million in cash - EssenBioScience.com / Sartorius.com



Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care

2017/03/01

NewswireToday (newswire) - 2017/03/01 Franklin Lakes, NJ United States - BD Awarded $100 Million Contract for Enterprise-Wide Automated Medication Dispensing Across 115 Military Health Facilities - BD.com



BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

2017/02/27

NewswireToday (newswire) - 2017/02/27 London, United Kingdom - BTG plc, the global specialist healthcare company, today announced U.S. Food and Drug Administration 510(k) clearance has been granted to the EKOS® Control Unit 4.0 - BTGplc.com